| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |